use of rechtsdrehendem 4 - (2 - isopropylamino 1 hydroxiethyl) - methansulfonanilid ('d - sotalol') to extend the duration of the action potential duration of cardiac muscle

摘要

A process is provided for preventing or ameliorating arrhythmia by administering to mammals, including man, an effective dose of d-sotalol to lengthen the action potential duration of cardiac cell without blockade of beta-adrenergic receptor sites.